Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra.

Langs-Barlow A, Renner L, Katz K, Northrup V, Paintsil E.

AIDS Res Treat. 2013;2013:249171. doi: 10.1155/2013/249171. Epub 2013 Mar 7.

PMID:
23533730
[PubMed]
Free PMC Article
2.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
[PubMed - indexed for MEDLINE]
3.

The Use of the Medical Dictionary for Regulatory Activities in the Identification of Mitochondrial Dysfunction in HIV-Infected Children.

Chernoff M, Ford-Chatterton H, Crain MJ.

Case Studies Bus Ind Gov Stat. 2012 Oct;5(1):17-31.

PMID:
23797349
[PubMed]
Free PMC Article
4.

Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.

Crain MJ, Chernoff MC, Oleske JM, Brogly SB, Malee KM, Borum PR, Meyer WA 3rd, Mitchell WG, Moye JH, Ford-Chatterton HM, Van Dyke RB, Seage Iii GR.

J Infect Dis. 2010 Jul 15;202(2):291-301. doi: 10.1086/653497.

PMID:
20533872
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
6.

Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.

Saitoh A, Fenton T, Alvero C, Fletcher CV, Spector SA.

Antimicrob Agents Chemother. 2007 Dec;51(12):4236-42. Epub 2007 Sep 24.

PMID:
17893156
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Differential restoration of myeloid and plasmacytoid dendritic cells in HIV-1-infected children after treatment with highly active antiretroviral therapy.

Zhang Z, Fu J, Zhao Q, He Y, Jin L, Zhang H, Yao J, Zhang L, Wang FS.

J Immunol. 2006 May 1;176(9):5644-51.

PMID:
16622034
[PubMed - indexed for MEDLINE]
Free Article
8.

Lymphocyte mitochondrial depolarization and apoptosis in HIV-1-infected HAART patients.

Karamchand L, Dawood H, Chuturgoon AA.

J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):381-8. doi: 10.1097/QAI.0b013e3181799662.

PMID:
18614930
[PubMed - indexed for MEDLINE]
9.

The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.

Patel K, Van Dyke RB, Mittleman MA, Colan SD, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219219C Study Team.

AIDS. 2012 Oct 23;26(16):2027-37. doi: 10.1097/QAD.0b013e3283578bfa.

PMID:
22781228
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy.

Guibert G, Warszawski J, Le Chenadec J, Blanche S, Benmebarek Y, Mandelbrot L, Tubiana R, Rouzioux C, Leruez-Ville M; French Perinatal Cohort.

Clin Infect Dis. 2009 Jun 1;48(11):1516-25. doi: 10.1086/598934.

PMID:
19388872
[PubMed - indexed for MEDLINE]
Free Article
11.

Impact on weight and height with the use of HAART in HIV-infected children.

Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA.

Pediatr Infect Dis J. 2007 Apr;26(4):334-8.

PMID:
17414398
[PubMed - indexed for MEDLINE]
12.

Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.

Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D.

BJOG. 2013 Nov;120(12):1534-47. doi: 10.1111/1471-0528.12226. Epub 2013 Aug 7.

PMID:
23924192
[PubMed - indexed for MEDLINE]
13.

Disparities in antiretroviral treatment: a comparison of behaviorally HIV-infected youth and adults in the HIV Research Network.

Agwu AL, Fleishman JA, Korthuis PT, Siberry GK, Ellen JM, Gaur AH, Rutstein R, Gebo KA; HIV Research Network.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):100-7. doi: 10.1097/QAI.0b013e31822327df.

PMID:
21637114
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.

Puthanakit T, Aurpibul L, Oberdorfer P, Akarathum N, Kanjananit S, Wannarit P, Sirisanthana T, Sirisanthana V.

Clin Infect Dis. 2007 Feb 15;44(4):599-604. Epub 2007 Jan 9.

PMID:
17243067
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.

Mosam A, Shaik F, Uldrick TS, Esterhuizen T, Friedland GH, Scadden DT, Aboobaker J, Coovadia HM.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):150-7. doi: 10.1097/QAI.0b013e318251aedd.

PMID:
22395672
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study.

Liu C, Wang C, Glesby MJ, D'souza G, French A, Minkoff H, Maurer T, Karim R, Young M.

AIDS Res Ther. 2013 Dec 27;10(1):34. doi: 10.1186/1742-6405-10-34.

PMID:
24373482
[PubMed]
Free PMC Article
17.

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine.

Macías J, Castellano V, Merchante N, Palacios RB, Mira JA, Sáez C, García-García JA, Lozano F, Gómez-Mateos JM, Pineda JA.

AIDS. 2004 Mar 26;18(5):767-74.

PMID:
15075511
[PubMed - indexed for MEDLINE]
18.

Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.

Ciccosanti F, Corazzari M, Soldani F, Matarrese P, Pagliarini V, Iadevaia V, Tinari A, Zaccarelli M, Perfettini JL, Malorni W, Kroemer G, Antinori A, Fimia GM, Piacentini M.

Antivir Ther. 2010;15(3):377-90. doi: 10.3851/IMP1530.

PMID:
20516557
[PubMed - indexed for MEDLINE]
19.

Thymic function in HIV-infection.

Kolte L.

Dan Med J. 2013 Apr;60(4):B4622. Review.

PMID:
23651726
[PubMed - indexed for MEDLINE]
20.

The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study.

Edmonds A, Yotebieng M, Lusiama J, Matumona Y, Kitetele F, Napravnik S, Cole SR, Van Rie A, Behets F.

PLoS Med. 2011 Jun;8(6):e1001044. doi: 10.1371/journal.pmed.1001044. Epub 2011 Jun 14.

PMID:
21695087
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk